Updated March 27, 2019

In response to the recent serogroup B meningococcal infections in two undergraduate students, all Rutgers University–New Brunswick undergraduate students, regardless of whether or not they live in campus housing, are strongly recommended to be fully vaccinated against serogroup B meningococcal (MenB).

The meningitis ACWY vaccine required for residential undergraduate students does not protect against meningitis B, which is the type that caused the infections on the Rutgers University–New Brunswick campus.

Two vaccines provide protection against serogroup B meningococcal disease: Bexsero®, given as a 2-dose series, and Trumenba®, given as a 3-dose series.

  • If you have not previously received a MenB vaccine, receive a first dose as soon as possible and
    complete the series with the same MenB vaccine.
  • If you have started but not completed a MenB vaccine series, complete the series with the same
    MenB vaccine.
  • If you completed a MenB series AND the last dose of the series was more than 1 year ago, get an
    additional dose with the same MenB vaccine to optimize protection during this outbreak.
  • After each dose is received, upload the signed form to the Rutgers Immunization Portal, https://rutgers.medicatconnect.com, AND enter the dates of vaccination.

Use the tools below to locations where you can get either Trumenba® or Bexsero® meningitis B vaccine:

Additionally, Rutgers Student Health will be holding vaccination clinics on campus. Click here for the dates and locations.

Information from NJDOH, including resources for clinicians, can be found here.